The promise of precision

Chair: Tim Maughan, University of Oxford, UK
Speaker: Peter O'Dwyer, University of Pennsylvania, USA
Speaker: Cindy Billingham, University of Birmingham, UK
Speaker: Rodrigo Dienstmann, Vall d'Hebron Institut d’Oncologia, Barcelona, Spain


Room: Hall 1

Precision medicine entails the delivery of treatment tailored to the individual based on genetic, clinical and other factors. Biomarker directed trials evaluate the efficacy of new therapeutic approaches in the patients considered most likely to benefit. The NCI Match trial is the most advanced example of this approach. This session will explore the biological underpinning, methodological approaches and the practical challenges of this clinical research strategy.